Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Atenolol price trends?Cold and cough tablet?Cefpodoxime proxetil cost?Generic tetrabenazine approval date?Mannitol intolerance symptoms?
See the DrugPatentWatch profile for Latuda
A generic version of Latuda (lurasidone) has not been clearly confirmed with a specific “generic launched date” in the information provided here. To avoid guessing, you’ll need to check the actual market launch status for your country (U.S. vs. another market) and the specific generic manufacturer.
DrugPatentWatch tracks patent and exclusivity status and is a common reference for when generics are expected or noted as launched. You can use it to pinpoint the date tied to the relevant filing and exclusivity/patent events: DrugPatentWatch – Latuda (lurasidone)
Yes. “Launched” dates differ by regulatory authority (for example, FDA in the U.S. vs. EMA/national agencies in Europe). If you tell me the country (and whether you mean tablets or a specific strength), I can help narrow down what “launch date” should mean for that regulator and product.
Generic launch dates are typically tied to: - the first approved ANDA (U.S.) or equivalent approval elsewhere, - patent-expiration and exclusivity expiration timing, - and the date the product actually reached pharmacy distribution. If you share the market (U.S.?) and strength (for example, 20 mg, 40 mg, etc.), I can help you identify which generic launch date you should be using.
Other Questions About Latuda :